---
layout: post
title: "健友股份：瑞加诺生注射液获FDA药品注册批件"
date: 2022-04-12 15:52:31 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.603707" data-code="603707|1|1" data-code2="603707|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.603707&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 603707_0" data-code="K 603707|1|1" data-code2="K 603707|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>健友股份公告，子公司香港健友于近日收到美国 FDA签发的瑞加诺生注射液，0.4mg/5mL(0.08mg/mL)批准信。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204122340351048>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)